HomeTrialNCT03844048
🔬NCT03844048Phase 3ACTIVE NOT RECRUITING

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Study Summary

The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment165 participants
Primary Completion
Lead SponsorAbbVie
Data Retrieved2026-04-11 02:51:51.325431+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.